MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "etc): Clinical features"

  • 2019 International Congress

    Jane Avril: Toulouse-Lautrec’s favourite courtisan and Moulin Rouge’s choreic dancer

    F. Germiniani, C. Camargo, G. Franklin, G. Ribas, L. Pinheiro, P. Marques, H. Teive (Curitiba, Brazil)

    Objective: Our aim is to analyse selected portraits of Jane Avril, Moulin Rouge's most famous dancer, done by Toulouse-Lautrec, in which some features of chorea…
  • 2019 International Congress

    Neurology Residents Versus a Mobile Medical Application in deducing differential diagnoses in Movement Disorders: A multi-center, cross-sectional, observational study

    V. Vishnu, P. Vinny, R. Rajan, V. Goyal, P. Srivastava, V. Lal, P. Sylaja, L. Narasimhan, S. Dwivedi, P. Nair, D. Ramachandran, A. Gupta (New Delhi, India)

    Objective: To test the hypothesis that the differentials generated by the  Mobile Medical Application  are more clinically relevant and complete to the ones derived by…
  • 2017 International Congress

    Screening of cognitive impairment in Huntington’s disease with the Parkinson’s Disease – Cognitive Rating Scale (PD-CRS)

    S. Martinez-Horta, A. Horta-Barba, J. Perez-Perez, J. Pagonabarraga, J. Marin-Lahoz, J. Kulisevsky (Barcelona, Spain)

    Objective: To explore the psychometric properties of the PD-CRS as compared to two commonly used measures (the MMSE and the UHDRS Cognitive score) for detecting…
  • 2017 International Congress

    Evidence-based Brazilian Physicaltherapy Guideline for Huntington´s Disease

    T. Capato, M. Haddad, E. Barbosa, M.E. Piemonte (Sao Paulo, Brazil)

    Objective: Identify the Evidence based Physicaltherapy available for HD and provide recommendations to physicians   Background: In Huntington’s Disease (HD) Chorea is usually presented in any phase…
  • 2017 International Congress

    Predictors for psychosis in Huntington’s disease: preliminary analysis of the Enroll-HD database.

    N. Rocha, E. Furr-Stimming, A. Teixeira (Houston, TX, USA)

    Objective: To evaluate predictors for psychosis in HD. Background: Behavioral problems are present across all stages of HD, even preceding the development of the motor…
  • 2017 International Congress

    Admission Diagnoses and Eventual Discharge Dispositions for Hospitalized Huntington’s Disease Patients: Results of a Nationwide Survey

    S. Gupta, F. Benesh, V. Sung (Birmingham, AL, USA)

    Objective: To better understand the causes of acute illness and its consequences for subsequent inpatient care in patients with Huntington’s Disease (HD). Background: HD is…
  • 2017 International Congress

    Examining central cognitive processing speed as an early marker of Huntington’s disease (HD) onset

    A. Nathan, S. Park, P. Gilbert, J. Corey-Bloom (La Jolla, CA, USA)

    Objective: To examine central processing speed as an early marker of Huntington’s disease (HD) onset using the Computerized Test of Information Processing (CTiP). Background: The CTiP,…
  • 2017 International Congress

    Depression among Inpatients with Huntington’s Disease: Patient Characteristics and Outcomes

    F.S. Benesh, S. Gupta, V. Sung (Birmingham, AL, USA)

    Objective: To better understand the relationship between Huntington’s Disease and depression. Background: Huntington’s Disease (HD) is an uncommon genetic neurodegenerative disorder in the United States…
  • 2017 International Congress

    Salivary biomarkers for Huntington’s disease (HD)

    J. Corey-Bloom, A. Aikin, S. Park, A. Haque, A. Nathan, D. Granger, S. Granger, E. Thomas (La Jolla, CA, USA)

    Objective: The objective of the current study was to assess the potential for saliva to serve as a biospecimen for accessible biomarkers for Huntington’s disease…
  • 2017 International Congress

    Social hindrances for diagnosing Huntington’s disease

    A. Alboudi, P. Sarathchandran, A.B. Almadani (Dubai, United Arab Emirates)

    Objective: The need to differentiate the malingering from real complains Careful history can give a strong clue for the diagnosis Criminals can have diseases also…
  • 1
  • 2
  • 3
  • …
  • 5
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley